International Journal of Gerontology
Volume 1, Issue 2 , Pages 98-102 , June 2007

Current Trends in Treating Cervical Cancer

  • Kung-Liahng Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • National Taipei College of Nursing, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Kung-Liahng Wang, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei 104, Taiwan

,Accepted 20 March 2007.

References 

  1. Taiwan Health and National Health Insurance Annual Statistics Information Service, 28 April, 2004. Available at http://www.doh.gov.tw/statistic/index.htm
  2. Walboomers JM , Jacobs MV , Manos MM , Bosch FX , Kummer JA , Shah KV , et al.   Human papillomavirus is a necessary cause of invasive cervical cancer worldwide . J Pathol . 1999;189:12–19
  3. Ostor AG . Studies on 200 cases of early squamous cell carcinoma of the cervix . Int J Gynecol Pathol . 1993;12:193–207
  4. Hacker NF . Chapter 9: Cervical cancer . In:  Berek JS ,  Hacker NF editor. Practical Gynecologic Oncology . 3rd edition. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 357
  5. Yang YC , Chang CL . Modified radical hysterectomy for early Ib cervical cancer . Gynecol Oncol . 1999;74:241–244
  6. Keys HM , Bundy BN , Stehman FB , Muderspach LI , Chafe WE , Suggs CL , et al.   Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma . N Engl J Med . 1999;340:1154–1161
  7. Morris M , Eifel PJ , Lu J , Grigsby PW , Levenback C , Stevens RE , et al.   Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer . N Engl J Med . 1999;340:1137–1143
  8. Chen SW , Liang JA , Hung YC , Yeh LS , Chang WC , Lin WC , et al.   Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications . Int J Radiat Oncol Biol Phys . 2006;66:1370–1377
  9. Ikushima H , Osaki K , Furutani S , Yamashita K , Kawanaka T , Kishida Y , et al.   Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin . Radiat Med . 2006;24:115–121
  10. Einstein MH , Novetsky AP , Garg M , Hailpern SM , Huang GS , Glueck A , et al.   Survival and toxicity differences between 5-day and weekly cisplatin in patients with locally advanced cervical cancer . Cancer . 2007;109:48–53
  11. Candelaria M , Garcia-Arias A , Cetina L , Duenas-Gonzalez A . Radiosensitizers in cervical cancer. Cisplatin and beyond . Radiat Oncol . 2006;1:15
  12. Wydra D , Sawicki S , Wojtylak S , Bandurski T , Emerich J . Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases . Int J Gynecol Cancer . 2006;16:649–654
  13. Vrdoljak E , Omrcen T , Novakovic ZS , Jelavic TB , Prskalo T , Hrepic D , et al.   Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix—final results of a prospective phase II-study . Gynecol Oncol . 2006;103:494–499
  14. Kim DS , Moon H , Kim KT , Hwang YY , Cho SH , Kim SR . Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumors . Gynecol Oncol . 1989;33:225–230
  15. Eddy GL , Manetta A , Alvarez RD , Williams L , Creasman WT . Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage Ib bulky cervical cancer: a gynecologic oncology group pilot study . Gynecol Oncol . 1995;57:412–416
  16. Benedetti Panici P , Scambia G , Greggi S , Di Roberto P , Baiocchi G , Mancuso S . Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study . Obstet Gynecol . 1988;71:344–348
  17. Kumar L , Biswal BM , Kumar S . Randomized phase III study of neoadjuvant chemotherapy + radiotherapy vs. radiotherapy alone in locally advanced cervical cancer . Proc Am Soc Clin Oncol . 1994;13:A819
  18. Tierney J  Neoadjuvant Chemotherapy for Cervical Cancer Meta-analysis Collaboration . Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials . Eur J Cancer . 2003;39:2470–2486
  19. Sardi JE , Boixadera MA , Sardi JJ . Neoadjuvant chemotherapy in cervical cancer: a new trend . Curr Opin Obstet Gynecol . 2005;17:43–47
  20. Thigpen JT , Shingleton H , Homesley H , Lagasse L , Blessing J . Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group . Cancer . 1981;48:899–903
  21. Stehman FB , Blessing JA , McGehee R , Barrett RJ . A phase II evaluation of mitolactol (NSC #104800) in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study . J Clin Oncol . 1989;7:1892–1895
  22. McGuire WP , Blessing JA , Moore D , Lentz SS , Photopulos G . Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study . J Clin Oncol . 1996;14:792–795
  23. Burnett AF , Roman LD , Garcia AA , Muderspach LI , Brader KR , Morrow CP . A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix . Gynecol Oncol . 2000;76:63–66
  24. Omura GA , Blessing JA , Vaccarello L , Berman ML , Clarke-Pearson DL , Mutch DG , et al.   Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study . J Clin Oncol . 1997;15:165–171
  25. Moore DH , Blessing JA , McQuellon RP , Thaler HT , Cella D , Benda J , et al.   Phase III study of cisplatin with or without paclitaxel in Stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study . J Clin Oncol . 2004;22:3113–3119
  26. Long HJ , Rayson S , Podratz KC , Abu-Ghazaleh S , Suman V , Hartmann LC , et al.   Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature . Am J Clin Oncol . 2002;25:547–551
  27. Long HJ , Bundy BN , Grendys EC , Benda JA , McMeekin DS , Sorosky J , et al.   Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix . J Clin Oncol . 2005;23:4626–4633
  28. Ljubojevic S . The human papillomavirus vaccines . Acta Dermatovenerol Croat . 2006;14:208
  29. Mahdavi A , Monk BJ . Vaccines against human papillomavirus and cervical cancer: promises and challenges . Oncologist . 2005;10:528–538
  30. Bourgault-Villada I . Anti Human-Papillomavirus vaccines: concepts, aims and trials . Rev Med Interne . 2007;28:22–27 [In French]
  31. Birle DC , Hedley DW . Signaling interactions of rapamycin combined with erlotinib in cervical carcinoma xenografts . Mol Cancer Ther . 2006;5:2494–2502

PII: S1873-9598(08)70029-2

doi: 10.1016/S1873-9598(08)70029-2

International Journal of Gerontology
Volume 1, Issue 2 , Pages 98-102 , June 2007

Article Tools